Abstract
An online survey was conducted among people living with HIV (PLHIV) in Australia to discern key factors associated with distinctive ART use patterns. The sample (N = 358), was further divided into three groups: those on ART continuously since initiation (n = 208, 58.1%); those on ART intermittently (n = 117, 32.7%); and those not on ART at the time of survey (n = 33, 9.2%). ART non-users were the most likely to hold serious concerns about ART that outweighed perceived necessities (benefits) from ART (AOR = 0.13; 95% CI 0.06–0.29; p < 0.001). They were also the least self-efficacious in HIV disease management (AOR = 0.29; 95% CI 0.09–0.87; p = 0.028). Intermittent ART users were more likely to receive their HIV diagnosis prior to 2003 (AOR = 0.38; 95% CI 0.28–0.53; p < 0.001) and perceive lower HIV management self-efficacy (AOR = 0.50, 95% CI 0.28–0.87; p = 0.015) than continuous users. ART-related beliefs and perceived self-efficacy in HIV self-management play an important role in achieving universal treatment uptake and sustained high levels of adherence.
Similar content being viewed by others
References
Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.
Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830–9.
Mao L, Adam PC, Kippax S, et al. Evolving views and practices of antiretroviral treatment prescribers in Australia. Med J Aust. 2015;202(5):258–60.
ASHM. 2013 antiretroviral guidelines with Australian commentary. Sydney: ASHM; 2013. http://arv.ashm.org.au/. Accessed 18 July 2016.
Amico KR, Orrell C. Antiretroviral therapy adherence support: recommendations and future directions. J Int Assoc Provid AIDS Care. 2013;12(2):128–37.
Ortego C, Huedo-Medina TB, Llorca J, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–96.
Elford J, Ibrahim F, Bukutu C, Anderson J. Uptake of antiretroviral treatment among people living with HIV in London: ethnicity, gender and sexual orientation. Sex Transm Infect. 2008;84(3):176–8.
Peretti-Watel P, Spire B, Schiltz MA, et al. Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients. Soc Sci Med. 2006;62(10):2420–33.
Stöhr W, Dunn DT, Porter K, et al. CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997–2003. HIV Med. 2007;8(3):135–41.
McNaghten AD, Hanson DL, Dworkin MS, Jones JL. Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients. J Acquir Immune Defic Syndr. 2003;32(5):499–505.
Whetten K, Reif S, Whetten R, Murphy-McMillan LK. Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. Psychosom Med. 2008;70(5):531–8.
Mao L, de Wit JB, Kippax SC, Prestage G, Holt M. Younger age, recent HIV diagnosis, no welfare support and no annual sexually transmissible infection screening are associated with nonuse of antiretroviral therapy among HIV-positive gay men in Australia. HIV Med. 2015;16(1):32–7.
Langebeek N, Gisolf EH, Reiss P, et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med. 2014;12:142.
Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS ONE. 2013;8(12):e80633.
Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24.
Horne R, Buick D, Fisher M, Leake H, Cooper V, Weinman J. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS. 2004;15(1):38–44.
Horne R, Cooper V, Fisher M. Initiation of therapy with a subcutaneously administered antiretroviral in treatment-experienced HIV-infected patients: understanding physician and patient perspectives. AIDS Care. 2008;20(9):1029–38.
Horne R, Cooper V, Gellaitry G, Date HL, Fisher M. Patients’ perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. J Acquir Immune Defic Syndr. 2007;45(3):334–41.
Horne R, Kovacs C, Katlama C, et al. Prescribing and using self-injectable antiretrovirals: how concordant are physician and patient perspectives? AIDS Res Ther. 2009;6:2.
Horne R, Weinman J. Self-regulation and self-management in Asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17(1):17–32.
Newman CE, Mao L, Persson A, et al. Not until I’m absolutely half-dead and have to: accounting for non-use of antiretroviral therapy in semi-structured interviews with people living with HIV in Australia. AIDS Patient Care STDs. 2015;29(5):267–78.
Persson A, Newman CE, Mao L, de Wit J. On the margins of pharmaceutical citizenship: not taking HIV medication in the “treatment revolution” era. Med Anthropol Q. 2016;30(3):359–77.
Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013;57(8):1164–71.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.
Mao L, Kidd MR, Rogers G, et al. Social factors associated with major depressive disorder in homosexually active, gay men attending general practices in urban Australia. Aust N Z J Public Health. 2009;33(1):83–6.
Duracinsky M, Lalanne C, Le Coeur S, et al. Psychometric validation of the PROQOL-HIV questionnaire, a new health-related quality of life instrument-specific to HIV disease. J Acquir Immune Defic Syndr. 2012;59(5):506–15.
Wallston KA, Osborn CY, Wagner LJ, Hilker KA. The perceived medical condition self-management scale applied to persons with HIV/AIDS. J Health Psychol. 2011;16(1):109–15.
The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2014 HIV Supplement. Sydney: The Kirby Institute, UNSW Australia; 2015.
Guy R, Wand H, McManus H, et al. Antiretroviral treatment interruption and loss to follow-up in two HIV cohorts in Australia and Asia: implications for ‘test and treat’ prevention strategy. AIDS Patient Care STDs. 2013;27(12):681–91.
Grierson J, Pitts M, Koelmeyer R. HIV futures seven: the health and wellbeing of HIV positive people in Australia. The Australian Research Centre in Sex, Health and Society, La Trobe Univeristy, Melbourne. 2013.
Linnemayr S, Stecher C. Behavioral economics matters for HIV research: the impact of behavioral biases on adherence to antiretrovirals (ARVs). AIDS Behav. 2015;19(11):2069–75.
van Velthoven MH, Brusamento S, Majeed A, Car J. Scope and effectiveness of mobile phone messaging for HIV/AIDS care: a systematic review. Psychol Health Med. 2013;18(2):182–202.
Acknowledgements
We acknowledge our key partner organisations (the National Association of People with HIV Australia, ASHM, the Australian Federation of AIDS Organisations, the Kirby Institute, NSW Ministry of Health, NSW Positive Central and Heterosexual HIV Service, Positive Life NSW and ACON) in this study. We are grateful to the contribution made by the study participants and the continuous support from jurisdiction-based HIV community organisations and networks throughout Australia.
Funding
This study is funded by the Australian National Health and Medical Research Council (APP1021790). The Centre for Social Research in Health is supported by the Australian Government Department of Health and Ageing. The researchers are independent from the funder.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that he/she has no conflict of interest.
Ethical Approval
The online survey was approved by UNSW Human Research Ethics Committee (# HC14183); ACON Research Ethics Review Committee (#RERC2014/18) and Victorian AIDS Council Research Committee (#VAC/RE&P 14/008). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committees (as declared above) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained (online) from all individual participants included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mao, L., de Wit, J., Adam, P. et al. Beliefs in Antiretroviral Treatment and Self-Efficacy in HIV Management are Associated with Distinctive HIV Treatment Trajectories. AIDS Behav 22, 887–895 (2018). https://doi.org/10.1007/s10461-016-1649-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-016-1649-6